Krishna Institute of Medical Sciences Limited
Символ: KIMS.BO
BSE
1965.3
INRПазарна цена днес
47.3315
Съотношение P/E
2.1556
Коефициент PEG
157.28B
MRK Cap
- 0.00%
Доходност на DIV
Krishna Institute of Medical Sciences Limited (KIMS-BO) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5821.16 | 1706.5 | 1899.9 | 2842.5 | ||||||||
balance-sheet.row.short-term-investments | 7206.07 | 1090.4 | 1643.5 | 2321.2 | ||||||||
balance-sheet.row.net-receivables | 5382.02 | 2718.9 | 1479.4 | 1373.8 | ||||||||
balance-sheet.row.inventory | 925.75 | 428.6 | 364.3 | 240.8 | ||||||||
balance-sheet.row.other-current-assets | 468.7 | 114.7 | 101.7 | 27.3 | ||||||||
balance-sheet.row.total-current-assets | 12405.26 | 4776.4 | 3934 | 4511.9 | ||||||||
balance-sheet.row.property-plant-equipment-net | 40415.47 | 18575.1 | 9094.3 | 8308 | ||||||||
balance-sheet.row.goodwill | 6160.14 | 3080.1 | 847.8 | 847.8 | ||||||||
balance-sheet.row.intangible-assets | 1503.36 | 777.4 | 317.6 | 247.4 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 7663.5 | 3857.4 | 1165.3 | 1095.2 | ||||||||
balance-sheet.row.long-term-investments | 941.37 | 61.7 | 3338.1 | 192.2 | ||||||||
balance-sheet.row.tax-assets | 783.99 | 401.9 | 32.1 | 29.4 | ||||||||
balance-sheet.row.other-non-current-assets | 1392.86 | 1740.5 | 1509.6 | 224.8 | ||||||||
balance-sheet.row.total-non-current-assets | 51197.19 | 24636.7 | 15139.5 | 9849.6 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 63602.45 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.account-payables | 3800.39 | 1742.5 | 1295.3 | 1318.7 | ||||||||
balance-sheet.row.short-term-debt | 988.79 | 445.8 | 302.1 | 884.3 | ||||||||
balance-sheet.row.tax-payables | 69.02 | 0 | 1.7 | 87 | ||||||||
balance-sheet.row.long-term-debt-total | 15349.24 | 6335.9 | 2263.2 | 2279.4 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 12.4 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 967.66 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 991.76 | 606.7 | 417.5 | 442.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 16810.14 | 7068.7 | 2817 | 2816.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 4548.34 | 1449.6 | 955 | 459 | ||||||||
balance-sheet.row.total-liab | 23376.43 | 10033.4 | 4967.1 | 5599.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 1600.56 | 800.3 | 800.3 | 775.9 | ||||||||
balance-sheet.row.retained-earnings | 5382.83 | 5382.8 | 2674.8 | -644.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 46768.44 | 11140.6 | 11140.6 | 9224 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 21301.72 | -628.4 | -742.6 | -718.3 | ||||||||
balance-sheet.row.total-stockholders-equity | 75053.55 | 16695.4 | 13873.1 | 8637.3 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 103828.47 | 29413 | 19073.5 | 14361.5 | ||||||||
balance-sheet.row.minority-interest | 5398.49 | 2684.2 | 233.3 | 124.6 | ||||||||
balance-sheet.row.total-equity | 80452.04 | 19379.6 | 14106.4 | 8762 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 103828.47 | - | - | - | ||||||||
Total Investments | 6206.55 | 566.9 | 3331.7 | 24.3 | ||||||||
balance-sheet.row.total-debt | 16338.03 | 6781.7 | 2565.3 | 3163.7 | ||||||||
balance-sheet.row.net-debt | 17722.94 | 6165.6 | 2308.9 | 2642.4 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 3379.47 | 4849.1 | 4568.5 | 2790.2 | ||||||||
cash-flows.row.depreciation-and-amortization | 1356.82 | 1292.6 | 726.7 | 695.4 | ||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -692.8 | -744.7 | 141.5 | ||||||||
cash-flows.row.account-receivables | 0 | -628.1 | -232.7 | 177.5 | ||||||||
cash-flows.row.inventory | 0 | 64.7 | -123.4 | 62.9 | ||||||||
cash-flows.row.account-payables | 0 | -410.8 | 101.2 | 239.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 281.4 | -489.7 | -338.1 | ||||||||
cash-flows.row.other-non-cash-items | -3379.47 | -1128 | -1310.3 | -67.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 3379.44 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.acquisitions-net | 0 | -2161.9 | -3240.9 | -352.7 | ||||||||
cash-flows.row.purchases-of-investments | 0 | -5392.8 | -5828.1 | -2409.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 7010.4 | 6520 | 113.8 | ||||||||
cash-flows.row.other-investing-activites | 0 | 133.6 | 137 | 51 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -6155.9 | -4115.2 | -3541.8 | ||||||||
cash-flows.row.debt-repayment | 0 | -2410.8 | -2334.4 | -1300.4 | ||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 1916.6 | 950.2 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 3294.2 | 1027.8 | 448.4 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 883.4 | 610 | 98.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1311.4 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | 2384.38 | 359.8 | -264.9 | 116.2 | ||||||||
cash-flows.row.cash-at-end-of-period | 2521.65 | 616.1 | 256.3 | 521.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 137.27 | 256.3 | 521.3 | 405.1 | ||||||||
cash-flows.row.operating-cash-flow | 3379.44 | 4320.9 | 3240.3 | 3559.7 | ||||||||
cash-flows.row.capital-expenditure | 0 | -5745.3 | -1703.2 | -944.3 | ||||||||
cash-flows.row.free-cash-flow | 3379.44 | -1424.3 | 1537 | 2615.5 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 24402.76 | 21976.8 | 16508.3 | 13122.1 | ||||||||
income-statement-row.row.cost-of-revenue | 9236.52 | 8270.8 | 6170.6 | 4931.1 | ||||||||
income-statement-row.row.gross-profit | 15166.24 | 13706 | 10337.6 | 8191 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 1791.07 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 197.39 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 141.32 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.operating-expenses | 10076.12 | 8958.4 | 5906.5 | 5063.8 | ||||||||
income-statement-row.row.cost-and-expenses | 19312.64 | 17229.3 | 12077.1 | 9995 | ||||||||
income-statement-row.row.interest-income | 0 | 61.1 | 122.8 | 58 | ||||||||
income-statement-row.row.interest-expense | 360.84 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 197.39 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | -219.5 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 141.32 | 258.7 | 202.6 | 36.1 | ||||||||
income-statement-row.row.total-operating-expenses | -219.5 | -99.5 | -198.2 | -381.9 | ||||||||
income-statement-row.row.interest-expense | 360.84 | 305.4 | 160.3 | 293.1 | ||||||||
income-statement-row.row.depreciation-and-amortization | 1356.79 | 1292.6 | 726.7 | 695.4 | ||||||||
income-statement-row.row.ebitda-caps | 6586.78 | - | - | - | ||||||||
income-statement-row.row.operating-income | 5090.08 | 4887.5 | 4558.7 | 3134 | ||||||||
income-statement-row.row.income-before-tax | 4869.15 | 4849.1 | 4568.5 | 2790.2 | ||||||||
income-statement-row.row.income-tax-expense | 1237.24 | 1190.9 | 1130.6 | 735.4 | ||||||||
income-statement-row.row.net-income | 3379.47 | 3363.2 | 3326.8 | 2012.2 |
Често задавани въпроси
Какво е Krishna Institute of Medical Sciences Limited (KIMS.BO) общи активи?
Krishna Institute of Medical Sciences Limited (KIMS.BO) общите активи са 29413030000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 12583180000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 42.228.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 42.228.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.138.
Какъв е общият приход на предприятието?
Общият приход е 0.209.
Каква е Krishna Institute of Medical Sciences Limited (KIMS.BO) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 3363220000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 6781740000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 8958440000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са -1037600000.000.